IL33 and infection: To determine the functional consequence of the upregulation of antiviral genes in MCs by IL-33, LAD2 MCs were pre-treated with IL-33 (1–10 ng/mL) for 24 h prior to infection with HRV16 (MOI 7.5) using UV-irradiated HRV16 as a control.